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181 patients undergoing resection of the
oesophagus for carcinoma were randomised to
receive selective decontamination (test group) or
conventional perioperative antibiotic prophylaxis
(controls). 114 patients were finally included in the
study: 12 of 56 test patients had 18 infections,
whereas 32 of 58 controls acquired 51 infections.
Colonisation with aerobic gram-negative
microorganisms, and the number of postoperative
respiratory tract infections were significantly
lower in the test patients. The postoperative
therapeutic use of antibiotics was significantly
lower in the test group. No endogenous infections
were caused by gram-negative bacilli in the test
group. Selective decontamination reduces
colonisation with gram-negative bacilli and
postoperative infections after resection of the
oesophagus.
Introduction
Hospital-acquired infections cause substantial morbidity
and mortality, especially on surgical wards and intensive
therapy units (ITU).1-10 Most of these infections are
endogenous-ie, they are preceded by colonisation of the
gastrointestinal tract and oropharynx by increasingly
multiresistant gram-negative bacilli (GNB).2-5,1l-14 Selective
decontamination (SD) is a procedure to eliminate these
organisms from the digestive tract leaving the anaerobic
flora unaffected. The anaerobes are part of the first-line
defence in the gut (colonisation resistance15), and they play
an important part in the prevention of overgrowth of
GNB.16 Results of earlier trials (in which non-absorbed
antibiotics were used) in granulocytopenic patients were
promising and use of SD in these patients has been
acceptedY,18 However, the benefit of modified regimens of
SD in intensive care patients remains controversial. A
reduction in infection rate from 81 to 16% was reported by
Stoutenbeek et a119 who used SD with systemic cefotaxime
in 122 multiple trauma patients with a moderately long
ITU-stay ( 5 days). Ledingham et al2l advocate the use of
this antibiotic regimen for unselected groups of patients in
non-specialised ITUs; they found a 24 to 10% reduction in
acquired infections in patients on a general ITU. A criticism
of previous trials is that historical controls and
heterogeneous patient-populations were studied.9
We here report a prospective, randomised study on the
effects of selective decontamination in a homogeneous
group of patients undergoing elective oesophageal resection
for carcinoma, we chose this group because there is a high
frequency of lower respiratory tract infections with GNB
due to lower colonisation resistance in such patients.
Patients and methods
Infection rate
To estimate the infection rate for oesophageal resection in our
hospital before the SD trial, we assessed data from 75 patients (54
men, 21 women; mean age 59 years, range 39-78) who had had
surgery for oesophageal carcinoma in 1985; they had been examined
by endoscopy, computed tomography, and ultrasonography. Only
patients who had no local ingrowth and no distant metastatic disease
were judged to be operable. Since 1983, cefamandole and
metronidazole (1 g and 500 mg, respectively four times a day, 24 h
perioperatively&mdash;ie,  1 h before until about 24 h after surgery)
were used as prophylaxis in this type of operation. Mean length of
time in hospital and ITU was 34 days (range 21-105) and 65 days
(1-48), respectively. Pneumonia developed in 16 pateints (21%),
urinary tract infection in 4 (5%), and septicaemia in 5 (7%); 5
patients (7%) died. The infection rate and mortality for the 5 years
before the study were similar to those for 1985 (20% and 5%,
respectively).
Patients and controls
Between March, 1986, and December, 1988, 181 patients who
were going to have surgery for oesophageal carcinoma were
included in the study. On admission to hospital the patients were
randomised (fixed block size, n = 8) and allocated either to a control
group (standard antibiotic prophylaxis) or to a test group (SD
medication combined with systemic cefotaxime during the first 4
days). For all patients the bowel was cleared ( laxatives and enemas)
during the 3 days before surgery. Until November 1986, a
combined right-sided thoracotomy and median upper laparotomy
was done on the 4th day. The oesophagus and tumour were
mobilised by blunt dissection through a laparotomy incision, and a
second incision in the neck was made to complete the
oesophagectomy; the upper digestive tract was reconstructed with a
tube made from the stomach, or by colonic interposition (table i).
The oesophageal resection was an important inclusion-criterium for
analysis.
67 patients were excluded from the study because oesophageal
resection was not done (tumour not resectable in 42 patients,
tumour of cardia not involving the oesophagus in 12); SD
medication was discontinued (non-compliance because of taste in 2,
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vomiting and nausea in 4, and allergy in 1); or other antibiotics had
been used preoperatively (6 patients). Thus, 114 patients (56 test
group, 58 control group) were studied. The trial was approved by
the hospital ethical committee and informed consent was given by
the patients.
Specific medication
SD medication consisted of a sticky ointment (’Orabase’,
Squibb), containing a mixture of 2% polymyxin E, 2% tobramycin,
and 2% amphotericin B, applied four times a day on buccal mucosa;
a suspension of the same drugs (200, 80, 500 mg, respectively) was
given at 6 h intervals by mouth, nasogastric tube, or needle
jejunostomy. This regimen was started on the day of admission, and
was continued until the 10th postoperative day (or longer if
infection had not resolved); specific antibiotics were also given. We
chose this period because the high risk for aspiration and other
respiratory disorders in these patients lessens quickly after 10 days,
as we had previously experienced. Systemic cefotaxime (I g, four
times a day) was added as supplementary prophylaxis for the first 3
days before surgery (SD is not yet fully established during this
time), and was discontinued after surgery (day + 1). On the day of
surgery, systemic metronidazole (500 mg, four times a day) is added
as part of the usual (24 h) prophylaxis in bowel surgery. Antibiotic
prophylaxis in the control group consisted of cefamandole and
metronidazole (1 g and 500 mg, respectively, four times a day), both
given systemically for 24 h perioperatively.
To assess the effect of this new antibiotic prophylaxis on the
possible development of resistance, we recorded all resistant strains
and compared the two groups.
Bacteriology
Cultures from nose, throat, sputum (when present), urine, and
faeces (or rectal swab) were taken on admission, and thereafter three
times a week. Drains, gastric contents, and feeding fistulae were also
cultured. Identification of pathogenic microorganisms and
antibiotic sensitivity tests were done according to usual laboratory
techniques. We defined primary infections as those that developed
within 48 h of admission; they are mostly caused by community-
acquired gram-positive microorganisms. Secondary infections,
were those that arose 48 h after hospital admission and we assumed
that these were hospital acquired; they are mostly caused by
gram-negative microorganisms.
Follow-up
All patients were examined daily for clinical signs of infection
during their admission; diagnosis of infection was confirmed by
culture. Chest radiographs were taken daily during the first 3
postoperative days and thereafter if clinically indicated.
Radiographs were judged by the same radiologist and chest
physician each time, both of whom were unaware of the group that
the patients had been allocated to. When a lower respiratory tract
infection was suspected cultures from lobular aspirations were taken
by bronchoscopy. In both groups treatment was only started when
there was clinical and microbiological evidence of infection.
Antibiotics were chosen according to hospital guidelines based on
the sensitivity patterns of the isolated organisms. In the test patients,
antibiotics that would not affect colonisation resistance were given.
None of the patients was given H2-blockers.
Statistical analysis
To detect a significant reduction in postoperative infections, 56
patients were needed in each group, with a and P at 0-05 (based on
the infection rate for oesophageal resection before the study). The X2
square test (with Yates’ correction) and Fisher’s exact test were used
to compare frequencies. To compare the number of infections and
non-infectious complications, we used the Mann-Whitney test. A p
value of 0-05 or less (Fisher, 0-025) was regarded as significant.
Results
Table I shows that the two groups were broadly similar. To
exclude any influence of a change in surgical technique on
infection rates, we analysed all infections in patients who had
had a thoracotomy (n = 36) and in those who had not had a
thoracotomy (n = 78). Infections developed in 13 (36%) and
33 patients (42%), respectively; lower respiratory tract
infections developed in 5 and 8 patients, respectively. These
differences were non-significant.
Colonisation rates
On the day of surgery, colonisation of the oropharynx,
rectum and urinary tract with potentially pathogenic
microorganisms was recorded in 7%, 11%, and 2% of test
patients, respectively. The overall colonisation rate with
aerobic GNB decreased significantly in test patients during
the first 10 postoperative days (table II).
Infection rates
During the first 10 postoperative days, 32 controls had 51
infections whereas 12 test patients acquired 18 infections
(p < 0-001); there were significantly fewer respiratory tract
infections and minor wound infections in the test patients
(table II). All infections were secondary, except for 2 urinary
tract infections on admission, which were not included in
this analysis. Most infections were endogenous (test group
83%, controls 73%). In the control group 54% (46/85) of
the causative microorganisms were GNB (Pseudomonas sp,
Proteus sp, Klebsiella sp, Enterobacter sp, Acinetobacter sp,
Citrobacter sp, and Escherichia colz), 41% (35/85) were
gram-positive cocci (Staphylococcus epidermidis, S aureus,
TABLE I-PATIENT CHARACTERISTICS
TABLE II-COLONISATION DURING THE FIRST 10
POSTOPERATIVE DAYS
*p < 0 01 (J! test) for comparison between test parents and controls
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TABLE III-ACQUIRED INFECTIONS WITHIN FIRST 10 POSTOPERATIVE DAYS
* < 05, tp < 0 01, and tp < 0 001 for controls vs test patients
&sect;Not preceded by colonisation, 4 causative organisms
and Enterococcus sp) and 5% (4/85) were gram-negative
diplococci (Neisseria sp and Branhamella sp). By contrast,
in test patients GNB (Pseudomonas sp, Acinetobacter sp,
and E colt) accounted for 15% (4/27) of infections and
gram-positive cocci for 85% (p < 0-001, table 111). 12 new
infections arose in 4 test patients after SD treatment was
stopped at 10 days: 3 were respiratory tract infections. 2
patients had not had a previous infection, but were heavily
colonised with GNB after SD medication was discontinued.
Half the infections were gram-negative or mixed. 1
pulmonary tract infection, caused by GNB, developed in a
control patient. There was no increase in antibiotic
resistance.
In a small subgroup of patients (n = 26), who stayed for
more than 4 days on the ITU, the reduction in infectious
complications and the number of respiratory tract infections
after SD, was not significant. 5 controls got respiratory tract
infections compared with 1 test patient. The therapeutic use
of antibiotics postoperatively was significantly different in
the two groups; 25 controls and 11 test patients needed
specific antibiotics (p = 0-013,  test). During this study
until July 1988, 1 test patient was colonised with a resistant
strain of Acinetobacter; 2 controls were colonised, 1 with a
resistant Pseudemonas strain, and the other with a resistant
Acinetobacter strain. 3 test patients died (5%); in 2,
infections were contributory factors. In the control group, 2
patients (3%) died of non-infectious causes.
Discussion
We have shown that SD reduces postoperative infections
caused by GNB after oesophageal resection and one-stage
reconstruction. Factors that may have influenced infection
rates, such as a thoracotomy or colon interposition were
equally distributed among both groups; moreover, there
were no significant differences in postoperative infectious
complications for the two surgical procedures.
Between 1983 and the beginning of our study the systemic
prophylaxis indicated in this kind of operation2l was
cefamandole and metronidazole, 24 h perioperatively. We
decided to give the same systemic prophylaxis to the control
group to detect any influences on infection rates, even
though a different medication strategy was given to test
patients-namely, cefotaxime and metronidazole. We did
not expect the results to be influenced by this difference
because cefotaxime was used only pre-operatively and
during the first 24 h postoperatively, and cefamandole was
given to control patients for 24 h perioperatively. Mandelli
and colleagues22 did not find an effect of systemic
prophylaxis on the occurrence of early onset pneumonia in
patients in the ITU. Moreover, since the half-life of
cefotaxime does not exceed 1 h,23 we believe that the
influence of this drug on outcome was negligible. For better
comparability, metronidazole was given systemically to both
groups: the anaerobic gut flora are not affected because
intraluminal concentrations are too low.24
We did not do a double-blind study because knowledge of
culture results was essential to the physicians in charge of the
patients, and because surveillance cultures are an important
part of SD. The number of gram-positive infections in the
control group was striking, and indicates how important
such cultures are, since gram-positive organisms are not
eliminated by SD. Cultures are also necessary to detect the
development of resistance during the use of antibiotics. The
reason why the number of urinary tract infections was
non-significantly reduced with SD prophylaxis was
probably because most nosocomial urinary tract infections
are associated with instrumentation 2’and all of our patients
had indwelling urinary catheters.
That patients were rapidly colonised by GNB after
discontinuation of SD medication points to a protective
influence of SD, and suggests that SD prophylaxis in these
patients should be continued. We cannot comment about a
possible effect of SD on mortality because of the low
mortality rate in this group of patients.
Although the reduction in infection rate led to a
significant reduction in therapeutic use of antibiotics in the
test group, this reduction did not influence the length of
admission as noted by others.5.9 However, for how long a
patient stays in hospital depends on surgical complications,
which were equally distributed in both groups. Although we
could not show a beneficial influence of SD in those staying
for more than 4 days in the ITU, there was a substantial
reduction in the number of respiratory tract infections in this
small group who are highly susceptible to gram-negative
bacterial infections.Z’8
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MODERN VACCINES
Immunisation practice in developed countries
ADDRESS. Center for Prevention Services, Centers for Disease
Control, Atlanta, GA 30333, USA (A. R Hinman, MD, W. A.
Orenstein, MD).
Successful immunisation programmes require both
effective vaccines and effective systems to deliver them.
Developed countries, with their good access to target
populations, have often led the way; but even some of these
show unacceptably high morbidity from conditions
preventable by vaccines. This paper will focus on practice in
the thirty-two countries of the European Region of the
World Health Organisation (WHO), in North America, in
Japan, and in Australia.1
Most countries have their vaccine policies set by central
government, often in consultation with the private sector. In
the United States, for example, the US Public Health
Service has an Immunization Practices Advisory
Committee (ACIP) which develops recommendations for
vaccine use, primarily aiming at the public sector.7 To
ensure coordination with the private sector, the ACIP works
closely with the Committee on Infectious Diseases of the
American Academy of Pediatrics8 and the Task Force on
Immunization of the American College of Physicians.9 By
contrast, in the Federal Republic of Germany there is strong
local autonomy, with some physicians using a particular
vaccine (eg, pertussis) and others not.10
The vaccines in use
Almost all the countries under consideration now routinely
give DPT (diphtheria and tetanus toxoids and pertussis
vaccine), poliomyelitis vaccine (whether oral live attenuated
